NewsBenzingaUBS Maintains Neutral on Dow, Lowers Price Target to $30 UBS Maintains Neutral on Dow, Lowers Price Target to $30 Benzinga 2026.09.25 16:12 (GMT+0) Open on Benzinga Other news US Stocks Hit by Panic Selling, but Multiple Wall Street Institutions Say It May Just Be a Bull Market Correction Gates Industrial Corporation Ltd. (GTES) Analyst/Investor Day - Slideshow BioMarin Pharmaceutical Inc. (BMRN) Presents at Jefferies London Healthcare Conference - Slideshow Orion Energy Systems, Inc. (OESX) Presents at 18th Annual Southwest IDEAS Conference - Slideshow Inhibrx Biosciences, Inc. (INBX) Presents at 2026 Connective Tissue Oncology Society (CTOS) Annual Meeting - Slideshow Biohaven Ltd. (BHVN) Presents at 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) - Slideshow
US Stocks Hit by Panic Selling, but Multiple Wall Street Institutions Say It May Just Be a Bull Market Correction
Inhibrx Biosciences, Inc. (INBX) Presents at 2026 Connective Tissue Oncology Society (CTOS) Annual Meeting - Slideshow
Biohaven Ltd. (BHVN) Presents at 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) - Slideshow